| For: | Yang T, Lau WY, Zhang H, Huang B, Lu JH, Wu MC. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons’ perspective. World J Gastroenterol 2015; 21(27): 8256-8261 [PMID: 26217077 DOI: 10.3748/wjg.v21.i27.8256] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8256.htm |
| Number | Citing Articles |
| 1 |
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget 2016; 7(38) doi: 10.18632/oncotarget.11358
|
| 2 |
Yongjiang Li, Yangxun Pan, Ximeng Lin, Jingyu Hou, Zili Hu, Li Xu, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Dandan Hu. Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.819985
|
| 3 |
|
| 4 |
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?. Journal of Cancer Research and Clinical Oncology 2016; 142(12) doi: 10.1007/s00432-016-2260-y
|
| 5 |
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clinical 2016; 6 doi: 10.1016/j.bbacli.2016.10.001
|
| 6 |
Tian Yang, Han Zhang, Jun Han, Meng‐Chao Wu, Feng Shen. Reply. Hepatology 2017; 65(5) doi: 10.1002/hep.28980
|
| 7 |
Marco Maccauro, Gianluca Aliberti, Carlo Chiesa, Carlo Spreafico. Clinical Applications of Nuclear Medicine Targeted Therapy. 2018; doi: 10.1007/978-3-319-63067-0_11
|
| 8 |
Sameh A Lashen, Mohamed M Elshafei, Fahmy H Hablass, Eman A Alsayed, Asmaa A Hassan. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosis. Hepatobiliary & Pancreatic Diseases International 2020; 19(1) doi: 10.1016/j.hbpd.2019.11.004
|
| 9 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4) doi: 10.1371/journal.pone.0194922
|
| 10 |
Monica M. Matsumoto, Samdeep Mouli, Priyali Saxena, Ahmed Gabr, Ahsun Riaz, Laura Kulik, Daniel Ganger, Haripriya Maddur, Justin Boike, Steven Flamm, Christopher Moore, Aparna Kalyan, Kush Desai, Bartley Thornburg, Michael Abecassis, Ryan Hickey, Juan Caicedo, Karen Grace, Robert J. Lewandowski, Riad Salem. Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis. CardioVascular and Interventional Radiology 2021; 44(7) doi: 10.1007/s00270-021-02810-8
|
| 11 |
Gill Al-Kadhimi. Hepatocellular carcinoma: management of a complex and challenging condition. Gastrointestinal Nursing 2015; 13(Sup10) doi: 10.12968/gasn.2015.13.Sup10.S20
|
| 12 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1) doi: 10.14218/JCTH.2021.00179
|
| 13 |
Wen-Tao Yan, Bing Quan, Jiong-Jie Yu, Tian Yang. Should we invariably follow the current guidelines to treat our HCC patients?. Hepatobiliary & Pancreatic Diseases International 2019; 18(3) doi: 10.1016/j.hbpd.2019.01.005
|